Impact of Staging Concordance and Downstaging After Neoadjuvant Therapy on Survival Following Resection of Intrahepatic Cholangiocarcinoma: A Bayesian Analysis-Reference-Cited by-同舟云学术

Impact of Staging Concordance and Downstaging After Neoadjuvant Therapy on Survival Following Resection of Intrahepatic Cholangiocarcinoma: A Bayesian Analysis

Published:2023-04-08 Issue:8 Volume:30 Page:4799-4808
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Alaimo Laura,Moazzam Zorays,Lima Henrique A.,Endo Yutaka,Woldesenbet Selamawit,Ejaz Aslam,Cloyd Jordan,Guglielmi Alfredo,Ruzzenente Andrea,Pawlik Timothy M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-13429-z.pdf

Reference29 articles.

1. Wu L, Tsilimigras DI, Paredes AZ, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival. World J Surg. 2019;43(7):1777–87.

2. El-Diwany R, Pawlik TM, Ejaz A. Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am. 2019;28(4):587–99.

3. Hamad A, Ansari A, Li Y, et al. Short- and long-term outcomes following robotic and open resection for intrahepatic cholangiocarcinoma: a national cohort study. Surg Oncol. 2022;43:101790.

4. Alaimo L, Moazzam Z, Brown ZJ, et al. Application of hazard function to investigate recurrence of intrahepatic cholangiocarcinoma after curative-intent liver resection: a novel approach to characterize recurrence. Ann Surg Oncol. 2023;30(3):1340–9.

5. Amini N, Ejaz A, Spolverato G, et al. Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis. J Surg Oncol. 2014;110(2):163–70.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASO Author Reflections: Accuracy of Preoperative Staging and Downstaging After Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma;Annals of Surgical Oncology;2023-04-12